The contribution of the NH,-terminal polypeptide chain and of the Cys148 -Cys279 interchain disulphide bond to the enzyme activity of urokinase-type plasminogen activator (u-PA) was studied using site-specific mutagenesis. Recombinant single-chain u-PA (rscu-PA) variants were produced by transfecting Chinese hamster ovary cells with cDNA encoding des(Asn2 -Phel57)rscu-PA (rscu-PA with deletion of Asn2 -Phel57), [Ala279]rscu-PA (rscu-PA with Cys279jAla mutation) or des(Asn2 -Phel57)[Ala279]rscu-PA [des(Asn2 -Phel57)rscu-PA with Cys279jAla mutation].Des(Asn2 -Phel57)rscu-PA, [Ala279]rscu-PA and des(Asn2 -Phel57)[Ala279]rscu-PA, purified from conditioned cell culture medium, were obtained as nearly homogeneous single-chain molecules with M , approximately 30000, 54000 and 30000, and specific fibrinolytic activities on fibrin plates of (mean A SD; n = 3) 860 & 150 IU/mg, 43.0 f 2.5 IU/pg and 240 rt_ 20 IU/mg, respectively, compared to 69.0 & 4.3 IU/pg for wild-type rscu-PA obtained in the same expression system. The plasminogen activating potential in a buffer milieu of [Ald279]rscu-PA was somewhat lower than that of rscu-PA, but that of both deletion mutants was virtually abolished. In a human plasma milieu in vitro, consisting of a radiolabelled human plasma clot submerged in plasma, 50% clot lysis in 2 h required 6.5 pg/ml [Ala279]rscu-PA or 3.4 pg/ml rscu-PA, whereas with both deletion mutants no significant clot lysis was observed with up to 16 pg/ml. Treatment of [Ala279]rscu-PA or rscu-PA with plasmin resulted in quantitative conversion to two-chain molecules and was associated with an increase in specific amidolytic activity from about 600 IU/mg to 62.5 1U/pg for [Ala279]rscu-PA as compared to an increase from about 0.3 IU/pg to 75.0 IU/pg for rscu-PA. In contrast, no significant amidolytic activity could be generated by treatment of des(Asn2 -Phel57)rscu-PA or des(Asn2 -Phel57)[Ala279]rscu-PA with plasmin.The u-PA B-chain, isolated from plasmin-treated [Ala279]rscu-PA, had enzymic properties which were comparable to those of rtcu-PA, with respect to specific fibrinolytic activity, amidolytic activity, kinetics of plasminogen activation and clot-lysis activity in a human plasma milieu in vitro. Following bolus injection into hamsters, the plasma clearances were comparable (0.7 -1.1 ml/min) for wild-type rscu-PA and for the three truncated rscu-PA mutants.These results indicate that (a) deletion of residues Asn2 -Phel57 results in abolition of the enzyme activity of rscu-PA, (b) the interchain disulphide bond in u-PA is not required for the enzymic activity of scu-PA, (c) all the determinants required for the enzymic activity of two-chain u-PA are contained within the B-chain, and (d) the region comprising residues Asn2 -Phel57 of u-PA is not required for the rapid in vivo clearance. Abbrc.viution.7. u-PA, urokinasc-type plasminogen activator; scu-PA, single-chain u-PA ; rscu-PA, recombinant scu-PA, obtained by expression of cDNA cncoding u-PA in Chinese hamster ovary cells; rtcu-PA, recombinant two-chain u-P...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.